This course is aimed at researchers from institutes and industry and provides the essential knowledge for understanding the manufacturing process, scaling up, and the main methodologies and techniques for characterising pharmaceutical quality attributes, including the non-clinical and clinical requirements of nanomedicines.
Crucial topics will be explored, such as the R&D process (including phases, market context and experimental design), the regulatory framework (life cycle and management), and various advanced characterisation methodologies and techniques, such as spectroscopy, nuclear magnetic resonance, microscopy and in vitro/in vivo and in silico models, as well as nanotoxicology. The course also covers Regulatory Science, Ethics, Intellectual Property, Patents, Business Models and Market Opportunities related to Nanomedicines.
